GILDER GAGNON HOWE & CO LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$245,300
-54.8%
62,259
+21.9%
0.00%
-42.9%
Q2 2023$542,917
+25.5%
51,074
-1.7%
0.01%0.0%
Q1 2023$432,635
+107.4%
51,937
+129.8%
0.01%
+75.0%
Q4 2022$208,635
-71.9%
22,604
-60.9%
0.00%
-69.2%
Q3 2022$743,000
-3.5%
57,864
-0.8%
0.01%
-7.1%
Q2 2022$770,000
-93.5%
58,309
-89.7%
0.01%
-87.3%
Q1 2022$11,883,000
-53.8%
564,516
-47.4%
0.11%
-24.7%
Q4 2021$25,728,000
-10.0%
1,072,440
-4.5%
0.15%
-1.4%
Q3 2021$28,578,000
-31.9%
1,123,355
-9.8%
0.15%
-28.2%
Q2 2021$41,939,000
-14.7%
1,245,956
-1.6%
0.21%
-22.3%
Q1 2021$49,169,000
-46.0%
1,265,950
-13.9%
0.26%
-41.4%
Q4 2020$91,089,000
+82.5%
1,470,841
-1.3%
0.45%
+46.8%
Q3 2020$49,905,000
+33.4%
1,490,153
-5.1%
0.31%
+5.1%
Q2 2020$37,403,000
-3.2%
1,569,564
-6.9%
0.29%
-36.7%
Q1 2020$38,627,000
-25.3%
1,686,747
-7.7%
0.46%
-13.8%
Q4 2019$51,738,000
+28.3%
1,826,890
-2.6%
0.54%
+16.0%
Q3 2019$40,319,000
-25.8%
1,876,191
+0.8%
0.46%
-15.5%
Q2 2019$54,304,0001,861,6230.55%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders